STING
发表于 2025-3-25 06:15:16
http://reply.papertrans.cn/63/6227/622642/622642_21.png
扩张
发表于 2025-3-25 11:10:25
ch is the reason for command-level discretion). In order to make these adaptations, field units need access to contextual data about local conditions, and they need to be able to analyze that data in a changing variety of ways. These are exactly the benefits MAPADS provided the district personnel an
仇恨
发表于 2025-3-25 12:00:56
http://reply.papertrans.cn/63/6227/622642/622642_23.png
性别
发表于 2025-3-25 18:25:52
Beth Z. Clarkinterior of their apartment. ‘That’s my jacket I just put on the couch!’ They zoom in further. Several clicks later and they arrive at an overhead view of themselves hunched over the laptop. With their backs to the camera (if that is what it is), they stare at themselves staring at themselves. Cue m
jumble
发表于 2025-3-25 20:37:57
Imaging of the Axilla and Approaches to Node-Negative Versus Node-Positive Disease at Presentationrior to neoadjuvant systemic therapy is important to establish the nodal status at diagnosis. This was demonstrated by the ACOSOG Z1071, SENTINA, and SN FNAC prospective trials, which paved the way for limiting axillary surgery in the setting of neoadjuvant chemotherapy from standard axillary lymph
upstart
发表于 2025-3-26 02:40:20
http://reply.papertrans.cn/63/6227/622642/622642_26.png
nutrients
发表于 2025-3-26 08:15:26
Neoadjuvant Systemic Therapy for Breast Cancer Based on Underlying Tumor Biology a result, it is seldom appropriate to administer more intensive neoadjuvant treatment than would be recommended as adjuvant therapy if the patient had undergone primary surgery. This chapter addresses evolving neoadjuvant systemic therapy approaches based on underlying tumor biology. Neoadjuvant ch
巨大没有
发表于 2025-3-26 10:22:27
Surgical Management of the Axilla in Node-Negative and Node-Positive Disease at Diagnosispatients who are clinically node positive (cN+) at presentation, when >2 lymph nodes are removed, along with some other surgical technique modifications reviewed in detail in this chapter. The long-term oncologic outcome following SLNB without axillary lymph node dissection (ALND) for cN+ patients f
设想
发表于 2025-3-26 13:49:04
Surgical Considerations and Expectations in Patients Receiving Neoadjuvant Chemotherapy and Neoadjuvgement of the axilla after neoadjuvant endocrine therapy is understudied, but early data suggest that these patients may be managed similarly to up-front surgery patients. In all patient populations, it is important to recognize that factors aside from clinical and pathologic response can influence
障碍
发表于 2025-3-26 18:48:31
http://reply.papertrans.cn/63/6227/622642/622642_30.png